ArticleHeadache2026

Effectiveness and tolerability of galcanezumab for migraine prevention in patients ≥65 years: A real-life multicenter study.

Julia Peris-Subiza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.